Table 4 The ECVL and ECVc of the T2DMs patients without HT, controls, and cardiomyopathies
T2DMs without HT (n = 19) | Controls (n = 7) | Cardiomyopathies (n = 9) | ||||
---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | |
ECVL | 0.2860 | 0.0368 | 0.2672 | 0.0155 | 0.3086 | 0.0834 |
ECVc | 0.2786 | 0.0333 | 0.2593 | 0.0138 | 0.3086 | 0.0793 |
T2DMs without HT - Controls | Cardiomyopathies - controls | |||||
ΔECVL | 0.0188 | 0.0414 | ||||
ΔECVc | 0.0193 | 0.0493 | ||||
ΔECVc–ΔECVL | 0.0005 | 0.0079 | ||||
(ΔECVc–ΔECVL)/ΔECVL | 3% | 19% |